Cube Labs SpA

Cube Labs SpA EBIT Margin

The EBIT Margin (Operating Margin) of Cube Labs SpA (CUBE.MI) as of Oct 27, 2026 is 8.55 %. In the previous year, EBIT Margin (Operating Margin) was -39.99 % — a change of -121.38% (higher).

EBIT Margin

8.55 %

YoY

-121.38%

Last updated:

EBIT Margin (Operating Margin) of Cube Labs SpA is 2025 8.55 % . EBIT Margin (Operating Margin) of Cube Labs SpA was 2024 -39.99 % . It decreases by -121.38% higher compared to the previous year.

For Cube Labs SpA, the operating (EBIT) margin of 8.5% is down versus 36.6% a few years ago.

The Cube Labs SpA EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2020
36.38 EUR
Jan 1, 2021
36.60 EUR
Jan 1, 2022
4.77 EUR
Jan 1, 2023
-41.64 EUR
Jan 1, 2024
-39.99 EUR
Jan 1, 2025
8.55 EUR
The Cube Labs SpA EBIT Margin history
YEAREBIT MarginYoY
8.55 %-121.38%
-39.99 %-3.96%
-41.64 %-973.23%
4.77 %-86.97%
36.60 %+0.61%
36.38 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cube Labs SpA Stock analysis

What does Cube Labs SpA do? Cube Labs SpA generates revenue through healthcare technology services, focusing on creating and supporting companies from the R&D stage. The firm provides entrepreneurial and operational support for healthcare management and technology solutions, targeting global markets. It promotes and implements scientific research results in human health, biotechnology, and nanotechnology, serving clients seeking innovative healthcare technology integration. The company operates with a lean team of two full-time employees, leveraging its expertise in translating research into practical applications. Cube Labs SpA's business model centers on bridging the gap between scientific research and market-ready healthcare technology. By offering tailored support for startups in the healthcare sector, the company helps clients navigate the complexities of R&D commercialization. Its global operations allow it to serve clients across different regions, capitalizing on the increasing demand for advanced healthcare solutions. The firm's revenue streams are derived from its specialized services in healthcare technology development and implementation. The company's primary clients are healthcare technology startups and established firms looking to integrate scientific research into their operations. Cube Labs SpA supports these clients through its expertise in biotechnology and nanotechnology applications, delivering customized solutions that address specific market needs. With a focus on operational support and entrepreneurial guidance, the firm helps clients accelerate their time-to-market for innovative healthcare products. Cube Labs SpA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cube Labs SpA stock

EBIT Margin (Operating Margin) of Cube Labs SpA is 8.55 % in 2025.

EBIT Margin (Operating Margin) of Cube Labs SpA changed from -39.99 % to 8.55 %, representing a -121.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Cube Labs SpA since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Cube Labs SpA with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Cube Labs SpA

All Key Metrics — Cube Labs SpA